Literature DB >> 28752441

Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.

Jeffrey H Teckman1,2,3, Keith S Blomenkamp4.   

Abstract

Classical alpha-1 antitrypsin (a1AT) deficiency is an autosomal recessive disease associated with an increased risk of liver disease in adults and children, and with lung disease in adults (Teckman and Jain, Curr Gastroenterol Rep 16(1):367, 2014). The vast majority of the liver disease is associated with homozygosity for the Z mutant allele, the so-called PIZZ. These homozygous individuals synthesize large quantities of a1AT mutant Z protein in the liver, but the mutant protein folds improperly during biogenesis and approximately 85% of the molecules are retained within the hepatocytes rather than appropriately secreted. The resulting low, or "deficient," serum level leaves the lungs vulnerable to inflammatory injury from uninhibited neutrophil proteases. Most of the mutant Z protein molecules retained within hepatocytes are directed into intracellular proteolysis pathways, but some molecules remain in the endoplasmic reticulum for long periods of time. Some of these molecules adopt an unusual aggregated or "polymerized" conformation (Duvoix et al., Rev Mal Respir 31(10):992-1002, 2014). It is thought that these intracellular polymers trigger a cascade of intracellular injury which can lead to end-organ liver injury including chronic hepatitis, cirrhosis, and hepatocellular carcinoma (Lindblad et al., Hepatology 46(4):1228-1235, 2007). The hepatocytes with the largest accumulations of mutant Z polymers undergo apoptotic death and possibly other death mechanisms. This intracellular death cascade appears to involve ER stress, mitochondrial depolarization, and caspase cleavage, and is possibly linked to autophagy and redox injury. Cells with lesser burdens of mutant Z protein proliferate to maintain the liver cell mass. This chronic cycle of cell death and regeneration activates hepatic stellate cells and initiates the process of hepatic fibrosis. Cirrhosis and hepatocellular carcinoma then result in some patients. Since not all patients with the same homozygous PIZZ genotype develop end-stage disease, it is hypothesized that there is likely to be a strong influence of genetic and environmental modifiers of the injury cascade and of the fibrotic response.

Entities:  

Keywords:  Alpha-1 antitrypsin; Cirrhosis; ER stress; Fibrosis; Hepatocellular carcinoma; Liver; Pathology; Polymers; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 28752441     DOI: 10.1007/978-1-4939-7163-3_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Don't Miss the BoAAT: Correctly Diagnosing Acute-on-Chronic Liver Disease.

Authors:  Zain A Sobani; Graziella R Paniz; Morgan Wong; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

Review 2.  Liver fibrosis: Pathophysiology and clinical implications.

Authors:  Jennifer Berumen; Jacopo Baglieri; Tatiana Kisseleva; Kristin Mekeel
Journal:  WIREs Mech Dis       Date:  2020-07-26

3.  Alpha-1 Antitrypsin Induces Epithelial-to-Mesenchymal Transition, Endothelial-to-Mesenchymal Transition, and Drug Resistance in Lung Cancer Cells.

Authors:  Dong-Ming Wu; Teng Liu; Shi-Hua Deng; Rong Han; Ting Zhang; Jing Li; Ying Xu
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

Review 4.  Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis.

Authors:  Margarita A Sazonova; Vasily V Sinyov; Anastasia I Ryzhkova; Marina D Sazonova; Tatiana V Kirichenko; Victoria A Khotina; Zukhra B Khasanova; Natalya A Doroschuk; Vasily P Karagodin; Alexander N Orekhov; Igor A Sobenin
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 5.  Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Cells       Date:  2019-01-01       Impact factor: 6.600

6.  The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.

Authors:  Nazli Khodayari; Rejean L Wang; Regina Oshins; Yuanqing Lu; Michael Millett; Alek M Aranyos; Sayedamin Mostofizadeh; Yogesh Scindia; Tammy O Flagg; Mark Brantly
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

Review 7.  Alpha-1-antitrypsin: A possible host protective factor against Covid-19.

Authors:  Mariana Braccialli de Loyola; Thaís Tereza Aguiar Dos Reis; Guilherme Xavier Lyra Malcher de Oliveira; Julys da Fonseca Palmeira; Gustavo A Argañaraz; Enrique R Argañaraz
Journal:  Rev Med Virol       Date:  2020-08-26       Impact factor: 11.043

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.